Yuanyuan Wu
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 5
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 5
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Inflammasome and immune disorders 6
- Mitochondrial Function and Pathology 5
- Genomics, phytochemicals, and oxidative stress 4
- Immunology top 10%
- Immune cells in cancer 8
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Yuanyuan Wu
109 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 340
- Complementary and alternative medicine 148
- Pharmacology 155
- Molecular Biology 1.1k
- Immunology 339
Countries citing papers authored by Yuanyuan Wu
This map shows the geographic impact of Yuanyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Wu more than expected).
Fields of papers citing papers by Yuanyuan Wu
This network shows the impact of papers produced by Yuanyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Wu. The network helps show where Yuanyuan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanyuan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 20 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 43 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 0 | |
| 14 | 2021 | 45 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 4 | |
| 18 | 2020 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2013 | 25 |
About Yuanyuan Wu
Yuanyuan Wu is a scholar working on Biological Psychiatry, Pharmacology and Cancer Research, having authored 116 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immune cells in cancer (8 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), Inflammasome and immune disorders (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Mitochondrial Function and Pathology (5 papers), Cancer-related molecular mechanisms research (5 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Cancer Research (340 citations), Complementary and alternative medicine (148 citations) and Pharmacology (155 citations). Yuanyuan Wu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yin Lu, Aiyun Wang, Wenxing Chen, Xiaoke Zheng, Mengnan Zeng, Weisheng Feng, Pingping Shen, Xiaoman Li, Ruiqi Xu and Beibei Zhang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.